Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer

We evaluated the feasibility of using the kinetic of diffusion-weighted MRI (DWI) and the normalized apparent coefficient diffusion (ADC) map value as an early biomarker in patients treated by external beam radiotherapy (EBRT). Twelve patients were included within the frame of a multicenter phase II...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquier, David, Hadj Henni, Abderraouf, Escande, Alexandre, Tresch, Emmanuelle, Reynaert, Nick, Colot, Olivier, Lartigau, Eric, Betrouni, Nacim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039515/
https://www.ncbi.nlm.nih.gov/pubmed/29991748
http://dx.doi.org/10.1038/s41598-018-28817-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039515/
https://www.ncbi.nlm.nih.gov/pubmed/29991748
http://dx.doi.org/10.1038/s41598-018-28817-9

Ejemplares similares